Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium

被引:317
作者
Knable, MB
Barci, BM
Webster, MJ
Meador-Woodruff, J
Torrey, EF
机构
[1] Stanley Med Res Inst, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Stanley Brain Res Lab, Bethesda, MD 20814 USA
[3] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA
关键词
hippocampus; schizophrenia; bipolar disorder; depression; post mortem; neuropathology;
D O I
10.1038/sj.mp.4001471
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Between 1997 and 2002, 48 data sets from the hippocampus were produced on samples from the Stanley Neuropathology Consortium. From these data sets, 224 total measures were available from the various subdivisions of the hippocampus. An integrative analysis of these measures was performed using a multivariate, nonparametric analysis of variance ( ANOVA). ANOVA with correction for multiple comparisons indicated that parvalbumin-containing cells in CA2 were reduced in schizophrenia and bipolar disorder. In addition, reelin protein in the molecular layer of the dentate gyrus was decreased in schizophrenia, bipolar disorder, and depression at the trend level of statistical significance (P = 0.065). These results strongly suggest a dysfunction of inhibitory GABA-ergic interneurons in severe mental illness. Without correction for multiple comparisons, 31 measures were abnormal in at least one disease, whereas 11 measures would be expected to appear abnormal by chance. Abnormal molecules included measures of synaptic density or neuronal plasticity (reelin, SNAP-25, BDNF, Complexin I and II), as well as parvalbumin, tyrosine receptor kinase A, glucocorticoid receptors, glutamate NR1 receptor subunits, serotonin 5HT2(A) and 5HT1(B) receptors, and dopamine D-5 receptors.
引用
收藏
页码:609 / 620
页数:12
相关论文
共 56 条
[1]   Association analysis of polymorphic CGG repeat in 5′ UTR of the reelin and VLDLR genes with schizophrenia [J].
Akahane, A ;
Kunugi, H ;
Tanaka, H ;
Nanko, S .
SCHIZOPHRENIA RESEARCH, 2002, 58 (01) :37-41
[2]   Studies in animal models and humans suggesting a role of nerve growth factor in schizophrenia-like disorders [J].
Aloe, L ;
Iannitelli, A ;
Angelucci, F ;
Bersani, G ;
Fiore, M .
BEHAVIOURAL PHARMACOLOGY, 2000, 11 (3-4) :235-242
[3]  
Angelucci F, 2000, J NEUROSCI RES, V60, P783, DOI 10.1002/1097-4547(20000615)60:6<783::AID-JNR11>3.0.CO
[4]  
2-M
[5]  
Arnold SE, 1996, J COMP NEUROL, V367, P274, DOI 10.1002/(SICI)1096-9861(19960401)367:2<274::AID-CNE9>3.0.CO
[6]  
2-2
[7]   Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia [J].
Badner, JA ;
Gershon, ES .
MOLECULAR PSYCHIATRY, 2002, 7 (04) :405-411
[8]   Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder [J].
Bayer, TA ;
Schramm, M ;
Feldmann, N ;
Knable, MB ;
Falkai, P .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2000, 24 (06) :881-888
[9]   Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins [J].
Beasley, CL ;
Zhang, ZJ ;
Patten, I ;
Reynolds, GP .
BIOLOGICAL PSYCHIATRY, 2002, 52 (07) :708-715
[10]   Effect of age and neuroleptics on tyrosine hydroxylase-IR in sector CA2 of schizophrenic brain [J].
Benes, FM ;
Todtenkopf, MS .
NEUROREPORT, 1999, 10 (17) :3527-3530